Recommendations for overcoming challenges in the diagnosis of lysosomal acid lipase deficiency

References

• Bernstein DL, Hülkova H, Bialer MG, et al. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58:1230–1243.
   PubMed Web of Science ®Google Scholar
• Scott SA, Liu B, Nazarenko I, et al. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology. 2013;58:958–965.
   PubMed Web of Science ®Google Scholar
• Abramov A, Schorr S, Wolman M. Generalized xanthomatosis with calcified adrenals. AMA J Dis Child. 1956;91:282–286.
   PubMedGoogle Scholar
• Wolman M, Sterk VV, Gatt S, et al. Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics. 1961;28:742–757.
   PubMed Web of Science ®Google Scholar
• Crocker AC, Vawter GF, Neuhauser EB, et al. Wolman’s disease: three new patients with a recently described lipidosis. Pediatrics. 1965;35:627–640.
   PubMed Web of Science ®Google Scholar
• Patrick A, Lake B. Deficiency of an acid lipase in wolman’s disease. Nature. 1969;222:1067–1068.
   PubMed Web of Science ®Google Scholar
• Guazzi GC, Martin JJ, Philippart M, et al. Wolman’s disease. Eur Neurol. 1968;1:334–362.
   PubMedGoogle Scholar
• Konno T, Fujii M, Watanuki T, et al. Wolman’s disease: the first case in Japan. Tohoku J Exp Med. 1966;90:375–389.
   PubMed Web of Science ®Google Scholar
• Marshall WC, Ockenden BG, Fosbrooke AS, et al. Wolman’s disease. A rare lipidosis with adrenal calcification. Arch Dis Child. 1969;44:331–341.
   PubMed Web of Science ®Google Scholar
• Young EP, Patrick AD. Deficiency of acid esterase activity in Wolman’s disease. Arch Dis Child. 1970;45:664–668.
   PubMed Web of Science ®Google Scholar
• Sachdev V, Duta-Mare M, Korbelius M, et al. Impaired bile acid metabolism and gut dysbiosis in mice lacking lysosomal acid lipase. Cells. 2021;10(10):2619.
   PubMed Web of Science ®Google Scholar
• Pastores GM, Hughes DA. Lysosomal acid lipase deficiency: therapeutic options. Drug Des Devel Ther. 2020;14:591–601.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18:e1003583.
   PubMed Web of Science ®Google Scholar
• Lowden JA, Barson AJ, Wentworth P. Wolman’s disease: a microscopic and biochemical study showing accumulation of ceroid and esterified cholesterol. Can Med Assoc J. 1970;102(4):402–405.
   PubMed Web of Science ®Google Scholar
• BD L. The role of histochemical investigations in metabolic disorders affecting the liver. J Inherit Metab Dis. 1991;14:538–545.
   PubMed Web of Science ®Google Scholar
• Blaner WS, Obunike JC, Kurlandsky SB, et al. Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem. 1994;269:16559–16565.
   PubMed Web of Science ®Google Scholar
• Dairaku T, Iwamoto T, Nishimura M, et al. A practical fluorometric assay method to measure lysosomal acid lipase activity in dried blood spots for the screening of cholesteryl ester storage disease and Wolman disease. Mol Genet Metab. 2014;111:193–196.
   PubMed Web of Science ®Google Scholar
• Ž R, Guardamagna O, Nair D, et al. Lysosomal acid lipase deficiency an under-recognized cause of dyslipidaemia and liver dysfunction. Atherosclerosis. 2014;235:21–30.
   PubMed Web of Science ®Google Scholar
• Lazzara A, Daymont C, Ladda R, et al. Failure to thrive: an expanded differential diagnosis. J Pediatr Genet. 2019;8:27–32.
   PubMed Web of Science ®Google Scholar
• Bona G, Gallina MR, Dolfin G, et al. Prenatal diagnosis of heterozygosis in a pregnancy at risk for Wolman’s disease at the 8th week of gestation. Panminerva Med. 1989;31:180–182.
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Yogev Y, Levit O, et al. Isolated fetal ascites caused by Wolman disease. Ultrasound Obstet Gynecol. 2003;21:297–298.
   PubMed Web of Science ®Google Scholar
• Staretz-Chacham O, Lang TC, LaMarca ME, et al. Lysosomal storage disorders in the newborn. Pediatrics. 2009;123:1191–1207.
   PubMed Web of Science ®Google Scholar
• Desai PK, Astrin KH, Thung SN, et al. Cholesteryl ester storage disease: pathologic changes in an affected fetus. Am J Med Genet. 1987;26:689–698.
   PubMed Web of Science ®Google Scholar
• Coates PM, Cortner JA, Mennuti MT, et al. Prenatal diagnosis of Wolman disease. Am J Med Genet. 1978;2:397–407.
   PubMed Web of Science ®Google Scholar
• Patrick AD, Willcox P, Stephens R, et al. Prenatal diagnosis of Wolman’s disease. J Med Genet. 1976;13:49–51.
   PubMed Web of Science ®Google Scholar
• van Diggelen OP, von Koskull H, Ammälä P, et al. First trimester diagnosis of Wolman’s disease. Prenat Diagn. 1988;8:661–663.
   PubMed Web of Science ®Google Scholar
• Al Essa M, Nounou R, Sakati N, et al. Wolman’s disease: the king faisal specialist hospital and research centre experience. Ann Saudi Med. 1998;18:120–124.
   PubMed Web of Science ®Google Scholar
• Pericleous M, Kelly C, Wang T, et al. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2:670–679.
   PubMed Web of Science ®Google Scholar
• Strebinger G, Müller E, Feldman A, et al. Lysosomal acid lipase deficiency - early diagnosis is the key. Hepat Med. 2019;11:79–88.
   PubMed Web of Science ®Google Scholar
• Rothe G, Stöhr J, Fehringer P, et al. Altered mononuclear phagocyte differentiation associated with genetic defects of the lysosomal acid lipase. Atherosclerosis. 1997;130(1–2):215–221.
   PubMed Web of Science ®Google Scholar
• Koch C, Kopp P. Korbonits M et al editors. Rare Genetic Disorders Altering Lipoproteins. Endotext [Internet]. South Dartmouth (MA)s: MDText.com; 2018.
   Google Scholar
• Sloan HR, Fredrickson DS. Enzyme deficiency in cholesteryl ester storage disease. J Clin Invest. 1972;51:1923–1926.
   PubMed Web of Science ®Google Scholar
• Nascimbeni F, Dionisi Vici C, Vespasiani Gentilucci U, et al. AISF rare diseases committee AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement. Dig Liver Dis. 2020;52:359–367.
   PubMedGoogle Scholar
• Vázquez-Frias R, JE G-O, Pf V-M, et al. Mexican consensus on lysosomal acid lipase deficiency diagnosis. Rev Gastroenterol Mex (Engl Ed). 2018; 83: 51–61.
   Google Scholar
• Dutton RV. Wolman’s disease Ultrasound and CT diagnosis. Pediatr Radiol. 1985;15:144–146.
   PubMed Web of Science ®Google Scholar
• Ozmen MN, Aygün N, Kiliç I, et al. Wolman’s disease: ultrasonographic and computed tomographic findings. Pediatr Radiol. 1992;22:541–542.
   PubMed Web of Science ®Google Scholar
• Foladi N, Aien MT. CT features of Wolman disease (lysosomal acid lipase enzyme deficiency) - A case report. Radiol Case Rep. 2021;16:2857–2861.
   PubMedGoogle Scholar
• Schaub J, Janka GE, Christomanou H, et al. Wolman’s disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Eur J Pediatr. 1980;135:45–53.
   PubMed Web of Science ®Google Scholar
• Blitz MJ, Rochelson B, Sood M, et al. Prenatal sonographic findings in a case of Wolman’s disease. J Clin Ultrasound. 2018;46:66–68.
   PubMed Web of Science ®Google Scholar
• Park CC, Nguyen P, Hernandez C, et al., Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease. Gastroenterology. 2017. 152(3): 598–607.
   PubMed Web of Science ®Google Scholar
• Furlan A, Tublin ME, Yu L, et al. Comparison of 2D shear wave elastography, transient elastography, and MR elastography for the diagnosis of fibrosis in patients with nonalcoholic fatty liver disease. AJR Am J Roentgenol. 2020;214(1):W20–W26.
   PubMed Web of Science ®Google Scholar
• Loomba R, Cui J, Wolfson T, et al. Novel 3D magnetic resonance elastography for the noninvasive diagnosis of advanced fibrosis in NAFLD: a prospective study. Am J Gastroenterol. 2016;111:986–994.
   PubMed Web of Science ®Google Scholar
• Mansoor S, Collyer E, Alkhouri N. A comprehensive review of noninvasive liver fibrosis tests in pediatric nonalcoholic Fatty liver disease. Curr Gastroenterol Rep. 2015;17(6):23.
   PubMedGoogle Scholar
• Xiao G, Zhu S, Xiao X, et al. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: a meta-analysis. Hepatology. 2017;66:1486–1501.
   PubMed Web of Science ®Google Scholar
• Thelwall PE, Smith FE, Leavitt MC, et al. Hepatic cholesteryl ester accumulation in lysosomal acid lipase deficiency: non-invasive identification and treatment monitoring by magnetic resonance. J Hepatol. 2013;59:543–549.
   PubMed Web of Science ®Google Scholar
• Castro M, Rosati P, Boldrini R, et al. Wolman’s disease diagnosed by intestinal biopsy. Ital J Gastroenterol Hepatol. 1999;31:610–612.
   Google Scholar
• Kikuchi M, Igarashi K, Noro T, et al. Evaluation of jejunal function in Wolman’s disease. J Pediatr Gastroenterol Nutr. 1991;12:65–69.
   PubMedGoogle Scholar
• Boldrini R, Devito R, Biselli R, et al. Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy. Pathol Res Pract. 2004;200:231–240.
   PubMed Web of Science ®Google Scholar
• Drebber U, Andersen M, Kasper HU, et al. Severe chronic diarrhea and weight loss in cholesteryl ester storage disease: a case report. World J Gastroenterol. 2005;11:2364–2366.
   PubMed Web of Science ®Google Scholar
• Kyosen SO, Geocze S, Yamamoto MH, et al. Endoscopic findings in lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2019;68(6):e105.
   PubMedGoogle Scholar
• Hautekeete ML, Degott C, Benhamou JP. Microvesicular steatosis of the liver. Acta Clin Belg. 1990;45:311–326.
   PubMed Web of Science ®Google Scholar
• Celebi G, Cicek AF, Gurel H, et al. Microvesicular steatosis: a missed item in the management of nonalcoholic fatty liver disease? Acta Gastroenterol Belg. 2020;83:565–570.
   PubMedGoogle Scholar
• Forlano R, Mullish BH, Giannakeas N, et al., High-throughput, machine learning-based quantification of steatosis, inflammation, ballooning, and fibrosis in biopsies from patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020. 18(9): 2081–2090.e9.
   PubMed Web of Science ®Google Scholar
• Carter-Kent C, Brunt EM, Yerian LM, et al. Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2011;52:190–197.
   PubMed Web of Science ®Google Scholar
• Tandra S, Yeh MM, Brunt EM, et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011;55:654–659.
   PubMed Web of Science ®Google Scholar
• Tommaso AMA, Barra FFC, Hessel G, et al. Importance of liver biopsy in the diagnosis of lysosomal acid lipase deficiency: a case report. Rev Paul Pediatr. 2017;36:4.
   PubMedGoogle Scholar
• Burton BK, Silliman N, Marulkar S. Progression of liver disease in children and adults with lysosomal acid lipase deficiency. Curr Med Res Opin. 2017;33:1211–1214.
   PubMed Web of Science ®Google Scholar
• Hůlková H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopathology. 2012;60:1107–1113.
   PubMed Web of Science ®Google Scholar
• Lipiński P, Cielecka-Kuszyk J, Bożkiewicz-Kasperczyk A, et al. Progressive macrophage accumulation in lysosomal acid lipase deficiency. Mol Genet Metab Rep. 2020;23:100594.
   PubMed Web of Science ®Google Scholar
• Nègre-Salvayre A, Dagan A, Gatt S, et al. Use of pyrenemethyl laurate for fluorescence-based determination of lipase activity in intact living lymphoblastoid cells and for the diagnosis of acid lipase deficiency. Biochem J. 1993;294(3):885–891.
   PubMedGoogle Scholar
• Hamilton J, Jones I, Srivastava R, et al. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chim Acta. 2012;413:1207–1210.
   PubMed Web of Science ®Google Scholar
• Civallero G, De Mari J, Bittar C, et al. Extended use of a selective inhibitor of acid lipase for the diagnosis of Wolman disease and cholesteryl ester storage disease. Gene. 2014;539:154–156.
   PubMedGoogle Scholar
• Masi S, Chennamaneni N, Turecek F, et al. Specific substrate for the assay of lysosomal acid lipase. Clin Chem. 2018;64:690–696.
   PubMed Web of Science ®Google Scholar
• Garzón AG, Cian RE, Aquino ME, et al. Isolation and identification of cholesterol esterase and pancreatic lipase inhibitory peptides from brewer’s spent grain by consecutive chromatography and mass spectrometry. Food Funct. 2020;11:4994–5003.
   PubMed Web of Science ®Google Scholar
• Rajan S, de Guzman HC, Palaia T, et al. A simple, rapid, and sensitive fluorescence-based method to assess triacylglycerol hydrolase activity. J Lipid Res. 2021;62:100115.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Byrum RS, Coates PM, et al. Mutations at the lysosomal acid cholesteryl ester hydrolase gene locus in Wolman disease. Proc Natl Acad Sci U S A. 1994;91:2718–2722.
   PubMed Web of Science ®Google Scholar
• Stenson PD, Ball EV, Mort M, et al. Human Gene Mutation Database (HGMD). Hum Mutat. update. 2003;21:577–581.
   PubMed Web of Science ®Google Scholar
• Pisciotta L, Tozzi G, Travaglini L, et al. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants. Atherosclerosis. 2017;265:124–132.
   PubMedGoogle Scholar
• Santillán-Hernández Y, Almanza-Miranda E, Xin WW, et al. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency. World J Gastroenterol. 2015;21:1001–1008.
   PubMedGoogle Scholar
• Pullinger CR, Stock EO, Movsesyan I, et al. Identification and metabolic profiling of patients with lysosomal acid lipase deficiency. J Clin Lipidol. 2015;9(716–26.e1). 10.1016/j.jacl.2015.07.008.
   PubMedGoogle Scholar
• Corral P, Geller AS, Polisecki EY, et al. Unusual genetic variants associated with hypercholesterolemia in Argentina. Atherosclerosis. 2018;277:256–261.
   PubMedGoogle Scholar
• Carter A, Brackley SM, Gao J, et al. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD. J Hepatol. 2019;70:142–150.
   PubMed Web of Science ®Google Scholar
• Rashu EB, Junker AE, Danielsen KV, et al. Cholesteryl ester storage disease of clinical and genetic characterisation: a case report and review of literature. World J Clin Cases. 2020;8:1642–1650.
   Google Scholar
• Hooper AJ, Tran HA, Formby MR, et al. A novel missense LIPA gene mutation, N98S, in a patient with cholesteryl ester storage disease. Clin Chim Acta. 2008;398:152–154.
   PubMedGoogle Scholar
• Lee TM, Welsh M, Benhamed S, Chung WK. Intragenic deletion as a novel type of mutation in Wolman disease. Mol Genet Metab. 2011;104:703–705.
   PubMed Web of Science ®Google Scholar
• Lin P, Raikar S, Jimenez J, et al. Novel mutation in a patient with cholesterol ester storage disease. Case Rep Genet. 2015;2015:347342.
   PubMedGoogle Scholar
• Rojas-Malaga D, Matte U, Schmidt Cerski CT, et al. Detection of the E8SJM mutation in the LIPA gene, by real-time PCR, for the investigation of cholesteryl ester storage disease. An Fac med. 2017. 78:409–413;https://doi.org/10.15381/anales
   Google Scholar
• Stitziel NO, Fouchier SW, Sjouke B, et al. National heart, lung, and blood institute GO exome sequencing project. Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2013;33:2909–2914.
   PubMed Web of Science ®Google Scholar
• Cappuccio G, Donti TR, Hubert L, et al. Opening a window on lysosomal acid lipase deficiency: biochemical, molecular, and epidemiological insights. J Inherit Metab Dis. 2019;42:509–518.
   PubMedGoogle Scholar
• Kojima S, Watanabe N, Takashimizu S, et al. Senescent case of cholesterol ester storage disease that progressed to liver cirrhosis with a novel mutation (N250H) of lysosomal acid lipase gene. Hepatol Res. 2013;43:1361–1367.
   PubMedGoogle Scholar
• Akki AS, Chung SM, Rudolph BJ, et al. Differential diagnosis of a patient with lysosomal acid lipase deficiency: a case report. Lab Med. 2018;49(4):377–384.
   PubMed Web of Science ®Google Scholar
• Hůlková H, Ledvinová J, Asfaw B, et al. Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study. Virchows Arch. 2005;447:31–44.
   PubMed Web of Science ®Google Scholar
• Pham NA, Gal MR, Bagshaw RD, et al. A comparative study of cytoplasmic granules imaged by the real-time microscope, Nile Red and Filipin in fibroblasts from patients with lipid storage diseases. J Inherit Metab Dis. 2005;28:991–1004.
   PubMed Web of Science ®Google Scholar
• Valayannopoulos V, Mengel E, Brassier A, et al. Lysosomal acid lipase deficiency: expanding differential diagnosis. Mol Genet Metab. 2017;120:62–66.
   PubMedGoogle Scholar
• Haznedar P, Kuloğlu Z, Kansu A, et al. A rare cause of hepatomegaly in the childhood: lysosomal acid lipase deficiency. Turk J Gastroenterol. 2018;29:518–519.
   PubMedGoogle Scholar
• Marmontel O, Rollat-Farnier PA, Wozny AS, et al. Development of a new expanded next-generation sequencing panel for genetic diseases involved in dyslipidemia. Clin Genet. 2020;98:589–594.
   PubMed Web of Science ®Google Scholar
• Lazarte J, Hegele RA. Can genetic testing help in the management of dyslipidaemias? Curr Opinion in Lipidol. 2020;31:187–193.
   Google Scholar
• Zhang H. Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies. Curr Opin Lipidol. 2018;29:218–223.
   PubMed Web of Science ®Google Scholar
• Li F, Zhang H. Lysosomal acid lipase in lipid metabolism and beyond. Arterioscler Thromb Vasc Biol. 2019;39:850–856.
   PubMed Web of Science ®Google Scholar
• Alabbas F, Elyamany G, Alanzi T, et al. Wolman’s disease presenting with secondary hemophagocytic lymphohistiocytosis: a case report from Saudi Arabia and literature review. BMC Pediatr. 2021;21:72.
   PubMed Web of Science ®Google Scholar
• Tinsa F, Ben Romdhane M, Boudabous H, et al. A novel mutation c.153 C>A in a tunisian girl with wolman disease and unusual presentation: hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2019;41:e193–e196.
   PubMed Web of Science ®Google Scholar
• Chabchoub I, Boudabbous H, Maaloul I, et al. Hemophagocytic lymphohistiocytosis: a rare complication of an ultrarare lysosomal storage disease. J Pediatr Hematol Oncol. 2020;42:310–312.
   PubMedGoogle Scholar
• Taurisano R, Maiorana A, De Benedetti F, et al. Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation. Eur J Pediatr. 2014;173:1391–1394.
   PubMed Web of Science ®Google Scholar
• Santos Silva E, Klaudel-Dreszler M, Bakuła A, et al. Early onset lysosomal acid lipase deficiency presenting as secondary hemophagocytic lymphohistiocytosis: two infants treated with sebelipase alfa. Clin Res Hepatol Gastroenterol. 2018;42(5):e77–e82.
   PubMed Web of Science ®Google Scholar
• Notarnicola M, Osella AR, Caruso MG, et al. Nonalcoholic fatty liver disease: focus on new biomarkers and lifestyle interventions. Int J Mol Sci. 2021;22:3899.
   PubMed Web of Science ®Google Scholar
• Decarlis S, Agostoni C, Ferrante F, et al. Combined hyperlipidaemia as a presenting sign of cholesteryl ester storage disease. J Inherit Metab Dis. 2009;32(Suppl 1):S11–3.
   PubMed Web of Science ®Google Scholar
• Ferri F, Mischitelli M, Tozzi G, et al. Reduced lysosomal acid lipase activity in blood and platelets is associated with nonalcoholic fatty liver disease. Clin Transl Gastroenterol. 2020;11:e00116.
   PubMed Web of Science ®Google Scholar
• Carotti S, Lettieri-Barbato D, Piemonte F, et al. Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver. Cell Death Dis. 2021;12(12):1092.
   PubMed Web of Science ®Google Scholar
• Pasta A, Borro P, Cremonini AL, et al. Effect of a common missense variant in LIPA gene on fatty liver disease and lipid phenotype: new perspectives from a single-center observational study. Pharmacol Res Perspect. 2021;9(5):e00820.
   PubMedGoogle Scholar
• Karaosmanoglu AD, Onder O, Leblebici CB, et al. Cross-sectional imaging features of unusual adrenal lesions: a radiopathological correlation. Abdom Radiol (NY). 2021;46:3974–3994.
   PubMed Web of Science ®Google Scholar
• Bernstein DL, Desnick RJ. Desnick RJ Lysosomal acid lipase deficiency and hematologic cancer predisposition. Mol Genet Metab. 2020;129:S31.
   Google Scholar
• Lopez de Frutos L, García-González E, García-Rodríguez B, et al. Serum protein profile analysis in lysosomal storage disorders patients. Clin Chim Acta. 2020;510:430–436.
   PubMed Web of Science ®Google Scholar
• Hsu H, Roncolato F, Lee SH. Lysosomal acid lipase deficiency diagnosed in a patient presenting with acute myeloid leukaemia. Br J Haematol. 2021;194:228.
   PubMed Web of Science ®Google Scholar
• Helderman RC, Whitney DG, Duta-Mare M, et al. Loss of function of lysosomal acid lipase (LAL) profoundly impacts osteoblastogenesis and increases fracture risk in humans. Bone. 2021;148:115946.
   PubMed Web of Science ®Google Scholar
• Guardamagna O, Guaraldi F. Lysosomal acid lipase deficiency: could dyslipidemia drive the diagnosis? Curr Pediatr Rev. 2017;13:232–242.
   PubMed Web of Science ®Google Scholar
• Fowler DJ, Anderson G, Vellodi A, et al. Electron microscopy of chorionic villus samples for prenatal diagnosis of lysosomal storage disorders. Ultrastruct Pathol. 2007;31:15–21.
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Anagnostopoulou KK, Kostakou PM, et al. Primary and secondary hypertriglyceridaemia. Curr Drug Targets. 2009;10:336–343.
   PubMed Web of Science ®Google Scholar
• Rahman MS, Murphy AJ, Woollard KJ. Effects of dyslipidaemia on monocyte production and function in cardiovascular disease. Nat Rev Cardiol. 2017;14:387–400.
   PubMed Web of Science ®Google Scholar
• Porto AF. Lysosomal acid lipase deficiency: diagnosis and treatment of wolman and cholesteryl ester storage diseases. Pediatr Endocrinol Rev. 2014;12(Suppl 1):125–132.
   PubMed Web of Science ®Google Scholar
• Baratta F, Pastori D, Ferro D, et al. Reduced lysosomal acid lipase activity: a new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? World J Gastroenterol. 2019;25:4172–4180.
   PubMed Web of Science ®Google Scholar
• Cebolla JJ, Irún P, Mozas P, et al. Evaluation of two approaches to lysosomal acid lipase deficiency patient identification: an observational retrospective study. Atherosclerosis. 2019;285:49–54.
   PubMed Web of Science ®Google Scholar
• Kane JP, Stock E, Pullinger CR, et al. Identifying cases of cholesteryl ester storage disease in a tertiary lipid clinic. J Clin Lipidol. 2013;7(3):249.
   Google Scholar
• Sjouke B, Defesche JC, Jse DR, et al. Sequencing for LIPA mutations in patients with a clinical diagnosis of familial hypercholesterolemia. Atherosclerosis. 2016;251:263–265.
   PubMed Web of Science ®Google Scholar
• AIacocca MA, Wang J, Sarkar S, et al. Whole-gene duplication of PCSK9 as a novel genetic mechanism for severe familial hypercholesterolemia. Can J Cardiol. 2018;34:1316–1324.
   PubMed Web of Science ®Google Scholar
• López de Frutos L, JJ C, Irún P, et al. The erythrocyte osmotic resistance test as screening tool for cholesterol-related lysosomal storage diseases. Clin Chim Acta. 2018;480:161–165.
   PubMed Web of Science ®Google Scholar
• TM R, Mewies C, Hamilton J, et al., PATHFINDER Project Collaboration group. Identification of rare diseases by screening a population selected on the basis of routine pathology results-the PATHFINDER project: lysosomal acid lipase/cholesteryl ester storage disease substudy. J Clin Pathol. 2018;71:608–613.
   PubMed Web of Science ®Google Scholar
• Daniels SR, Greer FR. Committee on nutrition lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122:198–208.
   PubMed Web of Science ®Google Scholar
• Polimeni L, Pastori D, Baratta F, et al. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease. Intern Emerg Med. 2017;12:1159–1165.
   PubMed Web of Science ®Google Scholar
• Brown EE, Sturm AC, Cuchel M, et al. Genetic testing in dyslipidemia: a scientific statement from the National Lipid Association. J Clin Lipidol. 2020;14:398–413.
   PubMed Web of Science ®Google Scholar
• Basu P, Nair T, Farhat S, et al. Unrevealing a novel association of cholesterol ester storage disease (CESD) & non- alcoholic fatty liver disease(NAFLD)-a similar clinical spectrum with different etiology a prospective clinical study. J Hepatol. 2012;56(2):S508.
   Google Scholar
• Arnaboldi L, Ossoli A, Giorgio E, et al. LIPA gene mutations affect the composition of lipoproteins: enrichment in ACAT-derived cholesteryl esters. Atherosclerosis. 2020;297:8–15.
   PubMed Web of Science ®Google Scholar
• Lozano P, Henrikson NB, Morrison CC, et al. Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US preventive services task force. JAMA. 2016;316:634–644.
   Google Scholar
• Donovan GK, Wilson DP. Ethical dilemmas in pediatric lipidology. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000 . Mar 12 2021.
   Google Scholar
• Peterson AL, McBride PE. A review of guidelines for dyslipidemia in children and adolescents. Wmj. 2012;111(6):274–281.
   PubMedGoogle Scholar
• Grant DSL, Scott RD, Harrison TN, et al. Trends in lipid screening among adults in an integrated health care delivery system, 2009-2015. J Manag Care Spec Pharm. 2018;24:1090–1101.
   PubMed Web of Science ®Google Scholar
• Hudson SE, Feigenbaum MS, Patil N, et al. Screening and socioeconomic associations of dyslipidemia in young adults. BMC Public Health. 2020;20:104.
   PubMed Web of Science ®Google Scholar
• Shome DK, Al-Jishi E, Greally JF, et al. The middle-east connection of wolman disease. Saudi Med J. 2002;23:597–601.
   PubMed Web of Science ®Google Scholar
• Zlatkovic M, Stankovic I, Prokic D, et al. Patohistoloska dijagnostika bolesti nagomilavanja estra holesterola [Pathohistologic diagnosis of cholesterol ester storage disease]. Srp Arh Celok Lek. 2001;129:207–210.
   PubMedGoogle Scholar
• Elleder M, Poupĕtová H, Ledvinová J, et al. Deficit kyselé (lysozomální) lipázy Prehled ceských pacientů [Lysosomal acid lipase deficiency. Overview of Czech patients]. Cas Lek Cesk. 1999;138:719–724.
   PubMedGoogle Scholar
• Mnif K, Chabchoub A, Marrakchi Z, et al. La maladie de wolman [wolman disease]. Arch Pediatr. 1994;1:663–666.
   PubMed Web of Science ®Google Scholar
• Röyttä M, Fagerlund AS, Toikkanen S, et al. Wolman disease: morphological, clinical and genetic studies on the first Scandinavian cases. Clin Genet. 1992;42:1–7.
   PubMed Web of Science ®Google Scholar
• Wierzbicka-Rucińska A, Jańczyk W, Ługowska A, et al. Diagnostic and therapeutic management of children with lysosomal acid lipase deficiency (LAL-D) Review of the literature and own experience. Dev Period Med. 2016;20:212–215.
   PubMedGoogle Scholar
• Ikari N, Shimizu A, Asano T. Lysosomal acid lipase deficiency in Japan: a case report of siblings and a literature review of cases in Japan. J Nippon Med Sch. 2018;85:131–137
   Google Scholar
• Lipiński P, Ługowska A, Zakharova EY, et al. Diagnostic algorithm for cholesteryl ester storage disease: clinical presentation in 19 polish patients. J Pediatr Gastroenterol Nutr. 2018;67:452–457.
   PubMed Web of Science ®Google Scholar
• Consuelo-Sánchez A, Vázquez-Frias R, Reyes-De La Rosa A, et al. Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency. Ann Hepatol. 2019;18:646–650.
   PubMed Web of Science ®Google Scholar
• Benevides GN, Miura IK, Person NC, et al. Lysosomal acid lipase deficiency in Brazilian children: a case series. J Pediatr (Rio J). 2019;95:552–558.
   PubMed Web of Science ®Google Scholar
• Botero V, Garcia VH, Gomez-Duarte C, et al. Lysosomal acid lipase deficiency, a rare pathology: the first pediatric patient reported in Colombia. Am J Case Rep. 2018;19:669–672.
   PubMed Web of Science ®Google Scholar
• Yang D, Ren X, Lu Y, et al. Current diagnosis and management of rare pediatric diseases in China. Intractable Rare Dis Res. 2021;10(4):223–237.
   PubMed Web of Science ®Google Scholar
• Draijer LG, Bosch AM, Wiegman A, et al. Screening for lysosomal acid lipase deficiency: a retrospective data mining study and evaluation of screening criteria. Atherosclerosis. 2018;278:174–179.
   PubMed Web of Science ®Google Scholar
• Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2013;56:682–685.
   PubMed Web of Science ®Google Scholar
• Huang YL, Sheng HY, Zhao XY, et al. wolman disease with novel mutation of LIPA gene in a Chinese infant. Zhonghua Er Ke Za Zhi. 2012;50:601–605.
   PubMedGoogle Scholar
• Mahdi AH, Al-Mashhadani SA, Al-Nasser M. Wolman’s disease in a Jordanian infant. Ann Trop Paediatr. 1991;11:305–308.
   PubMed Web of Science ®Google Scholar
• Surve TY, Muranjan MN, Barucha BA. Wolman disease: diagnosis by leucocyte acid lipase estimation. Indian J Pediatr. 2005;72:353–354.
   PubMedGoogle Scholar
• Kim KY, Kim JW, Lee KJ, et al. A novel homozygous LIPA mutation in a Korean child with lysosomal acid lipase deficiency. Pediatr Gastroenterol Hepatol Nutr. 2017;20:263–267.
   PubMed Web of Science ®Google Scholar
• Kuloglu Z, Kansu A, Selbuz S, et al. National LAL-D study group the frequency of lysosomal acid lipase deficiency in children with unexplained liver disease. J Pediatr Gastroenterol Nutr. 2019;68:371–376.
   PubMed Web of Science ®Google Scholar
• Burton BK, Deegan PB, Enns GM, et al. Clinical features of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2015;61:619–625.
   PubMed Web of Science ®Google Scholar
• Jones SA, Valayannopoulos V, Schneider E, et al. Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants. Genet Med. 2016;18:452–458.
   PubMed Web of Science ®Google Scholar
• Hoffman EP, Barr ML, Giovanni MA, et al. Lysosomal acid lipase deficiency. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle: University of Washington. 1993–2021; 2015 Jul 30. updated 2016 Sep 1.
   Google Scholar
• Gómez-Duarte C, García V, Botero V, et al. Deficiencia de lipasa ácida lisosomal, una patología infrecuente. Gac Med Mex. 2019;155:291–297.
   PubMedGoogle Scholar
• Giraldo P, Jenkins R, Bargiela R, et al. A novel enzymatic diagnosis method of lysosomal diseases. Mol Genet Metab. 2021;135:546.
   Web of Science ®Google Scholar
• Wilson DP, Patni N. Lysosomal acid lipase deficiency. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc; 2020 Jan 18 2000.
   Google Scholar
• Pant M, Oshima K. Cholesteryl ester storage disease: an underdiagnosed cause of cirrhosis in adults. Ann Diagn Pathol. 2017;31:66–70.
   PubMed Web of Science ®Google Scholar
• Polimeni L, Pastori D, Baratta F, et al. Spleen dimensions are inversely associated with lysosomal acid lipase activity in patients with non-alcoholic fatty liver disease. Intern Emerg Med. 2017;12:1159–1165.
   PubMed Web of Science ®Google Scholar
• Bay L, Canero Velasco C, Ciocca M, et al. Liver disease and dyslipidemia as a manifestation of lysosomal acid lipase deficiency (LAL-D) Clinical and diagnostic aspects, and a new treatment. An update. Arch Argent Pediatr. 2017;115:287–293.
   PubMed Web of Science ®Google Scholar
• Camarena C, Aldamiz-Echevarria LJ, Polo B, et al. Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management. Med Clin (Barc). 2017;148(9):429.e1–429.e10.
   PubMedGoogle Scholar
• Baragetti A, Bonacina F, Catapano AL, et al. Effect of lipids and lipoproteins on hematopoietic cell metabolism and commitment in atherosclerosis. Immunometabolism. 2021;3(2):e210014.
   PubMedGoogle Scholar
• A-Kader HH. Lysosomal acid lipase deficiency: a form of non-obese fatty liver disease (NOFLD). Expert Rev Gastroenterol Hepatol. 2017;11:911–924.
   PubMed Web of Science ®Google Scholar
• Boenzi S, Deodato F, Taurisano R, et al. Evaluation of plasma cholestane-3β,5α,6β-triol and 7-ketocholesterol in inherited disorders related to cholesterol metabolism. J Lipid Res. 2016;57:361–367.
   PubMed Web of Science ®Google Scholar
• Schonfeld EA, Brown RS Jr. Genetic causes of liver disease: when to suspect a genetic etiology, initial lab testing, and the basics of management. Med Clin North Am. 2019;103:991–1003.
   PubMed Web of Science ®Google Scholar
• Poinsot P, Collardeau Frachon S, Restier L, et al. Childhood/adult-onset lysosomal acid lipase deficiency: a serious metabolic and vascular phenotype beyond liver disease-four new pediatric cases. J Clin Lipidol. 2017;11(167–177.e3). 10.1016/j.jacl.2016.11.008.
   PubMedGoogle Scholar
• Berberich AJ, Hegele RA. The role of genetic testing in dyslipidaemia. Pathology. 2019;51:184–192.
   PubMed Web of Science ®Google Scholar
• Reynolds T. Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis. J Clin Pathol. 2013;66:918–923.
   PubMed Web of Science ®Google Scholar
• Tylki-Szymańska A, Jurecka A. Lysosomal acid lipase deficiency: wolman disease and cholesteryl ester storage disease. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2014;35:99–106.
   PubMedGoogle Scholar
• Castro-Martínez MG, Banderas-Lares DZ, Ramírez-Martínez JC, et al. Prevalence of nonalcoholic fatty liver disease in subjects with metabolic syndrome. Cir Cir. 2012;80:128–133.
   PubMed Web of Science ®Google Scholar
• Guénard F, Houde A, Bouchard L, et al. Association of LIPA gene polymorphisms with obesity-related metabolic complications among severely obese patients. Obesity (Silver Spring). 2012;20:2075–2082.
   PubMed Web of Science ®Google Scholar
• Maciejko JJ. Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency. Am J Cardiovasc Drugs. 2017;17:217–231.
   PubMed Web of Science ®Google Scholar
• Oliveira AG, Fiorotto R. Novel approaches to liver disease diagnosis and modeling. Transl Gastroenterol Hepatol. 2021;6:19.
   PubMed Web of Science ®Google Scholar